NEUROMODULATION DEVICES MARKET ANALYSIS

Neuromodulation Devices Market, by Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Gastric Electric Stimulation Devices), by Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism and GIT Management and Others (Incontinence Management, etc.)) by End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Others (Nursing Facilities, etc.)) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3861
Pages :170
Formats :
Excel and PDF
Industry : Medical Devices

Neuromodulation Devices MarketSize and Trends

The global neuromodulation devices market is estimated to be valued at US$ 14.1 billion in 2023 and is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030).

Global Neuromodulation Devices

Market Segmentation:

The global neuromodulation devices market report is segmented into device type, application, end user, and region.

Based on device type, the market is segmented into spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, and gastric electric stimulation devices. Out of which, the spinal cord stimulation devices segment is expected to hold a dominant position in the global neuromodulation devices market during the forecast period, and this is attributed to the increasing product launches of spinal cord stimulation devices.

Based on application, the market is segmented into pain management, neurological and movement disorder management, musculoskeletal disorder management, metabolism and GIT management, and others (incontinence management, etc.). Out of which, the pain management segment is expected to hold a dominant position in the global neuromodulation devices market during the forecast period, and this is attributed to the increasing prevalence of musculoskeletal disorder among patients

Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialized clinics, and others (nursing facilities, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period, and this is attributed to the rising number of hospitals.